Security key
320703119
FIRST LT ACQUISITION GROUP I - *W EXP 03/14/202 (CLDIWS)
CUSIP: 320703119
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / *W EXP 03/14/202
- Total 13F shares
- 7,460,338
- Total 13F value
- $99,421
- Share change
- +595,530
- SEC-reported price per share
- $0.01
- Number of holders
- 15
- Value change
- +$7,135
- Number of buys
- 4
- Number of sells
- 3
Report period
Q3 2024
Institutions
15
Top holders
10
CLDIWS full security history
Ownership snapshot
Full 13F holder table
Calidi Biotherapeutics, Inc. SEC filings
Calidi Biotherapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CLDIWS - FIRST LT ACQUISITION GROUP I - *W EXP 03/14/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Polar Asset Management Pa...
Disclosed value leader
Polar Asset Management Pa...
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5
13F
Highest disclosed value: $4,330,272
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Polar Asset Management Partners Inc. has the largest disclosed position value at $4.33M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Polar Asset Management Partners Inc.'s linked filing trail.
Disclosed position value
Top 5
Polar Asset Management Partners Inc.
$4.33M
Stephen Thesing
$848.8K
Boris Radoslavov Minev
$764K
Thomas A. Vecchiolla
$657.2K
Tony T. Kalajian
$501.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. |
3/4/5
13F
10%+ Owner · Company
|
—
mixed-class rows
|
$4,330,272
412,800 shares
|
— | 19 Oct 2022 |
| First Light Acquisition Group, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
1,931,852 shares
|
— | 16 Jun 2023 |
| Stephen Thesing |
3/4/5
Chief Business Officer
|
—
denominator unverified
|
$848,779
471,544 shares
|
— | 12 Sep 2023 |
| Boris Radoslavov Minev |
3/4/5
Interim Chief Medical Officer
|
—
mixed-class rows
|
$764,024
455,818 shares
mixed-class rows
|
— | 17 Jun 2024 |
| Thomas A. Vecchiolla |
3/4/5
Director
|
—
mixed-class rows
|
$657,189
781,459 shares
mixed-class rows
|
— | 21 Dec 2023 |
| Tony T. Kalajian |
3/4/5
Chief Acctg Officer, Int. CFO
|
—
denominator unverified
|
$501,822
278,790 shares
|
— | 12 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
7,460,338
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
16
Q3 2024 holders
15
Holder diff
-1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|